Saifuzzaman Md, Morrison Rick, Zheng Zhaohua, Orive Stephanie, Hamilton Justin, Thompson Philip E, Al-Rawi Jasim M A
Pharmacy and Applied Science, La Trobe Institute for Molecular Science, La Trobe University, P.O. Box 199 Bendigo, VIC 3552, Australia.
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.
Bioorg Med Chem. 2017 Oct 15;25(20):5531-5536. doi: 10.1016/j.bmc.2017.08.022. Epub 2017 Aug 15.
A series of 40 7-(O-substituted)-2-morpholino-8-aryl-4H-benzo[e][1,3]oxazin-4-one derivatives was synthesized. They were prepared via synthesis of a key precursor, 8-bromo-7-hydroxy-2-morpholino-4H-benzo[e][1,3]oxazin-4-one 13 which was amenable to ether synthesis at the 7-position and Suzuki coupling at the 8-position. The 2 protons of 7-OCH in compounds 18g, 18h, 18i, 18l and 18m prove to be magnetically non-equivalent, atropisomerism (axial chirality), as result of sterically hindered rotation of the bulky 8-aryl-substituent. The products were evaluated for their activities against PI3K isoforms, DNA-PK and PDE3. The results showed that this substitution pattern has a deleterious effect on PI3K activities, which may arise from steric hindrance in the active site. PI3Kδ was somewhat more tolerant of this substitution particularly where 8-(4-methoxylphenyl) substituents were present (ICs∼2-3μM). Good activities against PDE3 were also obtained for compounds, with particular members of the 7-(2-pyridinyl) methoxy series 19 showing good inhibition (ICs∼2-3μM), comparable to previously described analogues. A piperazinyl derivative 26a effectively inhibited ADP-induced platelet aggregation with an IC of 8μM.
合成了一系列40种7-(O-取代)-2-吗啉基-8-芳基-4H-苯并[e][1,3]恶嗪-4-酮衍生物。它们是通过合成关键前体8-溴-7-羟基-2-吗啉基-4H-苯并[e][1,3]恶嗪-4-酮13制备的,该前体适合在7位进行醚合成以及在8位进行铃木偶联。化合物18g、18h、18i、18l和18m中7-OCH的2个质子被证明是磁不等价的,由于庞大的8-芳基取代基的空间位阻旋转,存在阻转异构现象(轴手性)。对产物进行了抗PI3K亚型、DNA-PK和PDE3活性的评估。结果表明,这种取代模式对PI3K活性有有害影响,这可能是由于活性位点的空间位阻所致。PI3Kδ对这种取代的耐受性稍高,特别是在存在8-(4-甲氧基苯基)取代基的情况下(IC50约为2-3μM)。化合物对PDE3也具有良好的活性,7-(2-吡啶基)甲氧基系列19的特定成员表现出良好的抑制作用(IC50约为2-3μM),与先前描述的类似物相当。一种哌嗪基衍生物26a以8μM的IC50有效抑制ADP诱导的血小板聚集。